On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer…
Patients who are cancer survivors may require education on a wide variety of topics, from nutrition to long-term follow-up needs. It’s vital that nurses ensure…
What happens to patients once they reach the maximum benefit of traditional curative treatment? For many, hospice should be considered. A point on the…
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients.…
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about preventative health…
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with…
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about…